New York State Common Retirement Fund Denali Therapeutics Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 144,724 shares of DNLI stock, worth $3.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144,724
Previous 149,908
3.46%
Holding current value
$3.37 Million
Previous $4.37 Million
32.47%
% of portfolio
0.0%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding DNLI
# of Institutions
226Shares Held
119MCall Options Held
60.6KPut Options Held
48.4K-
Black Rock Inc. New York, NY13.2MShares$307 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$287 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$260 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$250 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$184 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.13B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...